Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Presented at September 1994 Valuation Actuary Symposium. This session presents the approaches of a stock and a mutual company to surplus management, and the application of recent research in risk theory to surplus management.

Description: An analysis of the 1999-2011 experience of all Blues plans of betweeen $1.8 and $3.8 billion in annual revenue in 2010 to determine if there is any empirical evidence of an industry underwriting cycle. The analysis shows there is no such evidence.

Description: This is the abstract of a paper that considers the pricing of equity-indexed annuities using risk measures and presents dynamic hedging strategies underlying these valuations. Since these products involve mortality as well as financial risks, the authors combine the actuarial and financial approaches to protect insurance companies against the unhedgeable mortality risk.

Description: The article provides an update on the 2019 ERM Symposium with regard to date, location and content (General Sessions and Concurrent Sessions).

Description: This is the strong message to encourage all actuaries in the world, who are struggling against low/zero/negative interest rate. Japanese actuaries have been struggling with low/zero/negative interest rate since 1995. There are experiences in asset management, product revision, pricing strategy, and capital management that can be applicable to other countries.

Description: Presented at October 1986 Annual Meeting. This session discussion is about how capital should be measured, cash flow based surplus, what performance measures are reliable, return on equity, book gains, terminal funds, how much surplus is needed, business planning for future capital needs, capital restructuring, how should multiple risks be combined and qualitative issues versus numbers as they relate to future growth.

Description: For several years there has been discussion in the insurance industry of the need for additional capital sources to participate in insuring the financial risk posed by natural catastrophes. A number of methods for accessing the capital markets have been introduced and some insurers are using these to hedge exposure to catastrophe loss. This paper summarizes some of the discussion and describes some of the methods proposed. It then focuses on one of these methods, the use of catastrophe insurance options. Results of simulations are given which may serve as a guide to insurers interested in using these options as part of their risk management strategy and also as an indication to investors of the value of these instruments as a new component of an investment portfolio.

Description: In this article, the author examines how a seemingly impossible event becomes a harsh or startling reality.

Description: This paper is Part 1 of a two-part submission. Part 2, “An Alternative Approach to Capital Allocation,” discusses using risk-replicating techniques that directly calculate the cost of capital. Such techniques can be used as a substitute for capital allocation. This paper expands upon current capital analysis by introducing a practical approach that considers the objectives of all stakeholders of an insurance company in setting appropriate capital targets.